socalTECH
FEBRUARY 7, 2014
Action sports camera maker GoPro --which has operations in San Diego--said Friday that it plans to conduct a registered, initial public offering of its stock. The company, which has headquarters in San Mateo, said it made a confidential submission of its draft registration statement Friday to the SEC. READ MORE>>.
socalTECH
MAY 7, 2010
Marc Friedmann: SciVee serves the STM - Science, Technical, Medical - market. What we offer to scientists which is proprietary in the videos, is we have a technique to link the videos to published documents and text. That approach allows you to synchronize the video you've uploaded to a document you've uploaded.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Both Sides of the Table
OCTOBER 19, 2009
Well … I have had many late nights and I really didn’t contemplate writing many blog postings this month because I spent November in this interesting venture capital / fund raising dance involving lots of late night sessions reviewing legal documents, rewriting business plans and preparing for pitches. We start getting on famously.
socalTECH
JUNE 21, 2013
The San Diego firm is headed by Ethan Senturia , who sat down with us to tell us how Dealstruck is trying to help build small businesses and jobs--and also tells us a bit about what it''s like to come from a family full of very successful, and high profile entrepreneurs, and how that has influenced his experience as an entrepreneur himself.
Xconomy
SEPTEMBER 23, 2016
But documents released by the FDA showed that eteplirsen was only approved after Janet Woodcock, the FDA’s top drug evaluator, went against the recommendations of outside experts and the agency’s own scientists and reviewers. Shares of Sarepta boomed and the Duchenne patient community cheered.
Xconomy
NOVEMBER 4, 2016
. —In the latest twist in the controversial approval saga of Sarepta Therapeutics’s (NASDAQ: SRPT ) Duchenne muscular dystrophy drug eteplirsen (Exondys 51), the FDA released a slew of internal documents and e-mails regarding its review of the treatment. ” ASH THURSDAY.
Expert insights. Personalized for you.
164 
Let's personalize your content